Cargando…
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
BACKGROUND: Since initial approval for the treatment of rheumatoid arthritis (RA), rituximab has been evaluated in clinical trials involving various populations with RA. Information has also been gathered from registries. This report therefore updates the 2007 consensus document on the use of rituxi...
Autores principales: | Buch, Maya H, Smolen, Josef S, Betteridge, Neil, Breedveld, Ferdinand C, Burmester, Gerd, Dörner, Thomas, Ferraccioli, Gianfranco, Gottenberg, Jacques-Eric, Isaacs, John, Kvien, Tore K, Mariette, Xavier, Martin-Mola, Emilio, Pavelka, Karel, Tak, Paul P, van der Heijde, Desiree, van Vollenhoven, Ronald F, Emery, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086093/ https://www.ncbi.nlm.nih.gov/pubmed/21378402 http://dx.doi.org/10.1136/ard.2010.144998 |
Ejemplares similares
-
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
por: Smolen, Josef S, et al.
Publicado: (2013) -
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement
por: Schoels, Monika M, et al.
Publicado: (2013) -
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
por: Stoffer, Michaela A, et al.
Publicado: (2016) -
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone
por: Keystone, Edward C, et al.
Publicado: (2017) -
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
por: Buch, Maya H, et al.
Publicado: (2015)